Theradaptive

Theradaptive's main focus is on developing new therapies to restore quality of life. With innovative protein engineering technology, the company guides tissue regeneration and enables the body to overcome healing barriers. Theradaptive transforms proteins into material-binding variants that can be used to coat implants, devices, and injectable carriers. This novel and unprecedented approach allows for precise delivery of therapeutic agents to any part of the body. The company is dedicated to vascular, soft tissue, and orthopedic repair, as well as targeted chemotherapy for previously inaccessible clinical indications, and has already demonstrated superiority over standard care in all preclinical studies.